Jonathan Davies

Partner
jdavies@cooley.com
Full contact info

About Jonathan

Jonathan’s practice focuses on patent litigation, with an emphasis on pharmaceutical and biotechnology cases, including Hatch-Waxman litigation related to abbreviated new drug applications (ANDAs) and biologics litigation under the Biologics Price Competition and Innovation Act (BPCIA).

View full bio

Experience

Liquidia Technologies Prevails in High Blood Pressure Drug Patent Litigation

Liquidia Technologies Prevails in High Blood Pressure Drug Patent Litigation

June 27, 2024

Cooley successfully defeated an inter partes review on behalf of Liquidia Technologies, a biopharmaceutical company focused on the development and commercialization of products to treat pulmonary hypertension, in United Therapeutics Corp. v. Liquidia Technologies Inc., case number 22-2133, in the US Court of Appeals for the Federal Circuit, relating to Liquidia’s high blood pressure drug patent.

Read more

Related contacts

Sanya Sukduang
Partner, Washington, DC
Jonathan Davies
Partner, Washington, DC
Brittany Cazakoff
Associate, Washington, DC
Robert Minn
Associate, Palo Alto
Rachel Preston
Associate, Washington, DC

Related Practices & Industries

Intellectual Property Litigation
Patent Office Litigation
Life Sciences
Intellectual Property
Life Sciences IP Litigation

Cooley Defeats Preliminary Injunction for Liquidia in Litigation With United Therapeutics

Cooley Defeats Preliminary Injunction for Liquidia in Litigation With United Therapeutics

June 3, 2024

Cooley successfully defeated a preliminary injunction filed by United Therapeutics that sought to block the launch of client Liquidia’s Yutrepia (treprostinil) inhalation powder for treatment of pulmonary hypertension associated with interstitial lung disease.

Read more

Related contacts

Sanya Sukduang
Partner, Washington, DC
Jonathan Davies
Partner, Washington, DC
Phillip Morton
Partner, Washington, DC
Lauren Strosnick
Associate, Palo Alto
Brittany Cazakoff
Associate, Washington, DC
Robert Minn
Associate, Palo Alto
John Habibi
Associate, Washington, DC
Rachel Preston
Associate, Washington, DC

Related Practices & Industries

Hatch-Waxman Litigation
Intellectual Property Litigation
Patent Office Litigation
Life Sciences IP Litigation
Intellectual Property
Life Sciences

Cooley Secures Win for Liquidia to Launch First Product

Cooley Secures Win for Liquidia to Launch First Product

April 5, 2024

Cooley successfully lifted a Hatch-Waxman injunction for Liquidia Technologies, a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products, enabling Liquidia to launch its new drug, Yutrepia.

Read more

Related contacts

Sanya Sukduang
Partner, Washington, DC
Jonathan Davies
Partner, Washington, DC
Ivor Elrifi
Partner, New York
Daniel Knauss
Partner, Palo Alto
Adam Pivovar
Partner, Washington, DC
Brittany Cazakoff
Associate, Washington, DC
Robert Minn
Associate, Palo Alto
Lauren Strosnick
Associate, Palo Alto
Jennifer Volk-Fortier
Associate, Washington, DC
Sam Whitt
Associate, Washington, DC
Larissa Diaz
Senior Paralegal, Washington, DC
Jeannine Douglas
Paralegal Specialist, Palo Alto
Melissa Eskola
Paralegal Specialist, Reston
Loreylys Feliciano
Paralegal Specialist, Chicago
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

Hatch-Waxman Litigation
Patent Office Litigation
Intellectual Property
Intellectual Property Litigation
Life Sciences IP Litigation
Life Sciences

Admissions and credentials

District of Columbia

Maryland

Memberships and affiliations

American Intellectual Property Law Association

Order of the Coif